Press Releases
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services, is pleased to announce that it will support Swiss Biotech...
Press Releases
Benchtop FT-NMR Applied to SARS-CoV-2 and ‘Long COVID’ Research Lowers the Barrier to Clinical Translation
Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and...
Press Releases
Authenticx Delivers Conversational Data Insights to the Life Sciences Industry
Authenticx, the new standard in healthcare for listening to customer voices at scale, has continued to innovate its product offerings and offer solutions to...
Press Releases
Nuvera PURE Reports name 2022 “best-in-class” pharmaceutical companies in oncology, neurology and immunology
Nuvera Life Science Consulting, part of Ashfield Engage, is pleased to announce its second annual awards for the three pharmaceutical companies designated as “best-in-class”...
Drug Research
EC Authorizes Opdualag From BMS As A Melanoma Treatment
The fixed-dose combination Opdualag (nivolumab and relatlimab) from Bristol Myers Squibb (BMS) has received clearance from the European Commission for use as the first-line...
News
GAVI Funds To Enable Quick Finances For The Next Pandemic
According to Chief Executive Seth Berkley of the global vaccination alliance GAVI, the organisation has set up financial structures that would enable it to...
Drug Research
Bluebird Hits $3m Mark With Gene Therapy After FDA Approval
Within one firm, the title of most costly treatment in the world has changed hands within a month.
Bluebird Bio has received an FDA fast...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read